EXTON, Pa.--(BUSINESS WIRE)--
Fibrocell Science, Inc. (NYSE MKT:FCSC), an autologous cell therapy company primarily focused on developing innovative products for skin diseases and conditions, announced today that David Pernock, Chairman and Chief Executive Officer, will present at the 3rd Annual Regenerative Medicine Partnering Forum, part of this years Stem Cell Meeting on the Mesa held October 14-16 in La Jolla, California.
Mr. Pernock will provide a corporate overview during the live presentation on Monday, October 14 at 5:30 p.m. PT in the La Jolla Ballroom CD&E of the Estancia La Jolla Hotel. He will be joined by the companys Chief Financial Officer, Greg Weaver.
Organized by the Alliance for Regenerative Medicine (ARM), the California Institute for Regenerative Medicine (CIRM) and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three-day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science into cures. The Regenerative Medicine Partnering Forum, held October 14 &15 at the Estancia La Jolla Hotel & Spa, is the only partnering meeting organized specifically for the regenerative medicine and advanced therapies industry.
The meeting also features a nationally recognized Scientific Symposium, held October 16 at the Salk Institute for Biological Studies, showcasing leading academic research in the field of regenerative medicine. Combined, these meetings attract over 800 attendees from around the globe, fostering key partnerships through one-on-one meetings while also highlighting clinical and commercial progress in the field.
A live video webcast of all company presentations will be available at http://stemcellmeetingonthemesa.com/webcast/ and will also be published on ARMs website and the Fibrocell Science website shortly after the event.
Please visit http://stemcellmeetingonthemesa.com/ for full information including registration. Complimentary attendance at this event is available for credentialed investors and members of the media only. Investors and media should contact Laura Parsons at lparsons@alliancerm.org.
About Fibrocell Science, Inc.
Fibrocell Science, Inc. (NYSE MKT:FCSC) is an autologous cell therapy company primarily focused on developing innovative products for skin diseases and conditions. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit http://www.fibrocellscience.com.
Forward-Looking Statements
Read the original:
Fibrocell Science to Present at 2013 Stem Cell Meeting on the Mesa